001     147318
005     20240229123022.0
024 7 _ |a 10.1017/S0007114519002538
|2 doi
024 7 _ |a pmid:31583990
|2 pmid
024 7 _ |a 0007-1145
|2 ISSN
024 7 _ |a 1475-2662
|2 ISSN
024 7 _ |a altmetric:70253505
|2 altmetric
037 _ _ |a DKFZ-2019-02439
041 _ _ |a eng
082 _ _ |a 570
100 1 _ |a Harms, Laura M
|b 0
245 _ _ |a Plasma polyphenols associated with lower high-sensitivity C-reactive protein concentrations: a cross-sectional study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort.
260 _ _ |a Cambridge
|c 2020
|b Cambridge Univ. Press
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1580472654_32441
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2020 Jan 28;123(2):198-208
520 _ _ |a Experimental studies have reported on the anti-inflammatory properties of polyphenols. However, results from epidemiological investigations have been inconsistent, and especially studies using biomarkers for assessment of polyphenol intake have been scant. We aimed to characterize the association between plasma concentrations of 35 polyphenol compounds and low-grade systemic inflammation state as measured by high-sensitivity C-reactive protein (hsCRP). A cross-sectional data analysis was performed based on 315 participants in the European Prospective Investigation into Cancer and Nutrition cohort with available measurements of plasma polyphenols and hsCRP. In logistic regression analysis the odds and 95% confidence intervals (CI-s) of elevated serum hsCRP (>3 mg/L) were calculated within quartiles and per standard deviation (SD) higher level of plasma polyphenol concentrations. In multivariable-adjusted model, the sum of plasma concentrations of all polyphenols measured (per SD) was associated with 29% lower odds of elevated hsCRP (95% CI: 50%-1%). In the class of flavonoids, daidzein was inversely associated with elevated hsCRP (OR= 0.66, 95%CI 0.46-0.96). Among phenolic acids, statistically significant associations were observed for 3,5-dihydroxyphenylpropionic acid (OR=0.58, 95%CI 0.39-0.86), 3,4-dihydroxyphenylpropionic acid (OR= 0.63, 95% CI 0.46-0.87), ferulic acid (OR= 0.65, 95%CI 0.44-0.96), and caffeic acid (OR= 0.69, 95%CI 0.51-0.93). The odds of elevated hsCRP were significantly reduced for hydroxytyrosol (OR= 0.67, 95%CI 0.48-0.93). This study showed that polyphenol biomarkers are associated with lower odds of elevated hsCRP. Whether diet rich in bioactive polyphenol compounds could be an effective strategy to prevent or modulate deleterious health effects of inflammation should be addressed by further well-powered longitudinal studies.
536 _ _ |a 313 - Cancer risk factors and prevention (POF3-313)
|0 G:(DE-HGF)POF3-313
|c POF3-313
|f POF III
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed,
700 1 _ |a Scalbert, Augustin
|b 1
700 1 _ |a Zamora-Ros, Raul
|0 0000-0002-6236-6804
|b 2
700 1 _ |a Rinaldi, Sabina
|b 3
700 1 _ |a Jenab, Mazda
|b 4
700 1 _ |a Murphy, Neil
|b 5
700 1 _ |a Achaintre, David
|b 6
700 1 _ |a Tjønneland, Anne
|b 7
700 1 _ |a Olsen, Anja
|b 8
700 1 _ |a Overvad, Kim
|b 9
700 1 _ |a Mancini, Francesca Romana
|b 10
700 1 _ |a Mahamat-Saleh, Yahya
|b 11
700 1 _ |a Boutron-Ruault, Marie-Christine
|b 12
700 1 _ |a Kühn, Tilman
|0 P:(DE-He78)0907a10ba1dc8f53f04907f54f6fdcfe
|b 13
|u dkfz
700 1 _ |a Katzke, Verena
|0 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4
|b 14
|u dkfz
700 1 _ |a Trichopoulou, Antonia
|b 15
700 1 _ |a Martimianaki, Georgia
|b 16
700 1 _ |a Karakatsani, Anna
|b 17
700 1 _ |a Palli, Domenico
|b 18
700 1 _ |a Panico, Salvatore
|b 19
700 1 _ |a Sieri, Sabina
|b 20
700 1 _ |a Tumino, Rosario
|b 21
700 1 _ |a Sacerdote, Carlotta
|b 22
700 1 _ |a Bueno-de-Mesquita, Bas
|b 23
700 1 _ |a Vermeulen, Roel C H
|b 24
700 1 _ |a Weiderpass, Elisabete
|b 25
700 1 _ |a Nøst, Therese Haugdahl
|b 26
700 1 _ |a Lasheras, Cristina
|b 27
700 1 _ |a Rodríguez-Barranco, Miguel
|b 28
700 1 _ |a Huerta, José María
|b 29
700 1 _ |a Barricarte, Aurelio
|b 30
700 1 _ |a Dorronsoro, Miren
|b 31
700 1 _ |a Hultdin, Johan
|b 32
700 1 _ |a Schmidt, Julie A
|b 33
700 1 _ |a Gunter, Marc
|b 34
700 1 _ |a Riboli, Elio
|b 35
700 1 _ |a Aleksandrova, Krasimira
|b 36
773 _ _ |a 10.1017/S0007114519002538
|g p. 1 - 35
|0 PERI:(DE-600)2016047-1
|n 2
|p 198-208
|t British journal of nutrition
|v 123
|y 2020
|x 1475-2662
909 C O |o oai:inrepo02.dkfz.de:147318
|p VDB
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 13
|6 P:(DE-He78)0907a10ba1dc8f53f04907f54f6fdcfe
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 14
|6 P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4
913 1 _ |a DE-HGF
|l Krebsforschung
|1 G:(DE-HGF)POF3-310
|0 G:(DE-HGF)POF3-313
|2 G:(DE-HGF)POF3-300
|v Cancer risk factors and prevention
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF3
|b Gesundheit
914 1 _ |y 2020
915 _ _ |a Allianz-Lizenz / DFG
|0 StatID:(DE-HGF)0400
|2 StatID
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0310
|2 StatID
|b NCBI Molecular Biology Database
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b BRIT J NUTR : 2017
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
915 _ _ |a WoS
|0 StatID:(DE-HGF)0110
|2 StatID
|b Science Citation Index
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
915 _ _ |a WoS
|0 StatID:(DE-HGF)0111
|2 StatID
|b Science Citation Index Expanded
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1060
|2 StatID
|b Current Contents - Agriculture, Biology and Environmental Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l Epidemiologie von Krebserkrankungen
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21